RETRACTED: Knockdown PEG10 deteriorates H2O2-injury of PC-12 cells by targeting miR-34a-5p/TLX (Publication with Expression of Concern. See vol. 141, pg. 346, 2022) (Retracted article. See vol. 144, pg. 178, 2022)

被引:5
|
作者
Niu, Shizhen [1 ]
Ni, Yong [2 ]
Niu, Tong [2 ]
Gao, Jianwen [2 ]
机构
[1] Jining Med Univ, Sch Clin Med, 16 Hehua Rd, Jining 272067, Shandong, Peoples R China
[2] Jining 1 PeopleS Hosp, Dept Spine Surg, Jining 272011, Shandong, Peoples R China
关键词
Spinal cord injury; lncRNA PEG10; miR-34a-5p; TLX; Smad and Wnt/beta-catenin pathways; SPINAL-CORD-INJURY; EXPRESSION; TLX; GENE;
D O I
10.1016/j.molimm.2019.11.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: Spinal cord injury (SCI) is a neurological disease with high incidence and disability. In this paper, we made a foundational study in long non-coding RNA paternally expressed gene 10 (lncRNA PEG10) at PC-12 cells. Methods: We used CCK8, flow cytometry, migration and invasion assay to detect changes at the cellular level. PEG10, microRNA-34a-5p (miR-34a-5p) and TLX transfected by transfection assay and amplified by real-time quantitative PCR (qRT-PCR). TLX expression and proteins about apoptosis and pathways were investigated by Western blot. Additionally, the relationship between PEG10 and miR-34a-5p, miR-34a-5p and TLX were examined through luciferase assay. Results: H2O2-injury model was established. Knockdown PEG10 deteriorated H2O2-injury. miR-34a-5p was confirmed as a target of PEG10 and miR-34a-5p inhibitor remitted PEG10-induced H2O2-injury. Moreover, TLX was confirmed as a target miR-34a-5p and TLX remitted H2O2-injury. At last, TLX worked in H2O2-injury via Smad and Wnt/beta-catenin pathways. Conclusion: Knockdown PEG10 remitted H2O2-injury of PC-12 cells by targeting miR-34a-5p/TLX, and the behavior may be involved in Smad and Wnt/beta-catenin pathways.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] RETRACTED: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID (Retracted article. See vol. 30, pg. 378, 2022)
    Xu, Yun-chao
    Liu, Xu
    Li, Min
    Li, Yan
    Li, Chun-yan
    Lu, Ying
    Sanches, Jaceline
    Wang, Lu
    Du, Yue
    Mao, Li-min
    Zuo, Si-bo
    Liu, Hui-ting
    Shen, Jie
    Wang, Bo
    Hou, Li
    Li, Lian-hong
    Tang, Jian-wu
    Ju, Jing-fang
    Guan, Hong-wei
    Song, Bo
    MOLECULAR THERAPY NUCLEIC ACIDS, 2018, 12 : 578 - 590
  • [42] RETRACTED: Ligustrazine Inhibits Growth, Migration and Invasion of Medulloblastoma Daoy Cells by Up-Regulation of miR-211 (Retracted article. See vol. 56, pg. 324, 2022)
    Xu, Donghui
    Chi, Guonan
    Zhao, Conghai
    Li, Dongyuan
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (05) : 2012 - 2021
  • [43] RETRACTED: miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells (Retracted article. See vol. 14, pg. 675, 2022)
    Li, Bai
    Ge, Liang
    Li, Minghe
    Wang, Lei
    Li, Zhihong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (07): : 3013 - 3022
  • [44] RETRACTED: TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells (Retracted article. See vol. 150, 2022)
    Jiang, Nianxin
    Xia, Jingwen
    Jiang, Bing
    Xu, Yinghui
    Li, Yansong
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 1669 - 1677
  • [45] RETRACTED: Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma (Retracted article. See vol. 30, pg. 346, 2022)
    Hou, Yi
    Fan, Li
    Li, Hai
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 24 : 92 - 103
  • [46] RETRACTED: miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1 (Retracted article. See vol. 45, pg. 423, 2023)
    Wang, Yi
    Wang, Li
    BIOTECHNOLOGY LETTERS, 2017, 39 (10) : 1485 - 1492
  • [47] RETRACTED: MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2 (Retracted article. See vol. 47, pg. 63, 2022)
    Li, Jibin
    Xu, Jian
    Yan, Xiaofei
    Jin, Keer
    Li, Wenya
    Zhang, Rui
    ONCOLOGY REPORTS, 2018, 40 (01) : 554 - 564
  • [48] RETRACTED: LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APEI Axis (Retracted article. See vol. 15, pg. 701, 2022)
    Lu, Ming-dian
    Liu, Dong
    Li, Yong-xiang
    ONCOTARGETS AND THERAPY, 2020, 13 : 10607 - 10619
  • [49] RETRACTED: miR-639 Expression Is Silenced by DNMT3A-Mediated Hypermethylation and Functions as a Tumor Suppressor in Liver Cancer Cells (Retracted article. See vol. 30, pg. 503, 2022)
    Xiao, Jing
    Liu, Yankun
    Wu, Fuxia
    Liu, Ruiyan
    Xie, Yongli
    Yang, Qian
    Li, Yufeng
    Liu, Min
    Li, Shengping
    Tang, Hua
    MOLECULAR THERAPY, 2020, 28 (02) : 587 - 598
  • [50] RETRACTED: Antitumor Effects of OSU-2S, a Nonimmunosuppressive Analogue of FTY720, in Hepatocellular Carcinoma (Retracted article. See vol. 76, pg. 1554, 2022)
    Omar, Hany A.
    Chou, Chih-Chien
    Berman-Booty, Lisa D.
    Ma, Yihui
    Hung, Jui-Hsiang
    Wang, Dasheng
    Kogure, Takayuki
    Patel, Tushar
    Terracciano, Luigi
    Muthusamy, Natarajan
    Byrd, John C.
    Kulp, Samuel K.
    Chen, Ching-Shih
    HEPATOLOGY, 2011, 53 (06) : 1943 - 1958